Cardiome Announces XYDALBA™ Single Dose Infusion Approval by European Medicines Agency
Go back to Cardiome Announces XYDALBA™ Single Dose Infusion Approval by European Medicines Agency| Impreso, Inc. (NYSE: COM) | Delayed: 35.82 +0.09 (0.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $35.73 | 52 Week High | $0.60 | |||
| Open | $35.60 | 52 Week Low | $0.60 | |||
| Day High | $35.82 | P/E | N/A | |||
| Day Low | $35.55 | EPS | $-0.26 | |||
| Volume | 134,574 | |||||
| CARDIOME PHARMA (NASDAQ: CRME) | Delayed: 2.33 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.33 | 52 Week High | $9.21 | |||
| Open | $28.95 | 52 Week Low | $2.35 | |||
| Day High | $2.33 | P/E | N/A | |||
| Day Low | $2.33 | EPS | $0.00 | |||
| Volume | 525 | |||||
